- Fellowship - UT Southwestern Medical Center (2010-2012), Toxicology
- Residency - Cook County Hospital Internal Medicine Residency Program (1996-2000), Occupational Medicine
- Undergraduate School - University of Illinois at Chicago School of Public Health (1992-1994), Public Health
- Internship - General Hospital (1988-1989), Rotating
- Medical School - Obafemi Awolowo College of Health Sciences (1980-1987)
Adebisi Obafemi, M.D.
- Internal Medicine - General Internal Medicine
- Adult Preventive Medicine
Dr. Obafemi received his initial medical training at the University of Ife in Nigeria. He completed his residency in Internal Medicine and occupational medicine at the Cook County Hospital in Chicago and a fellowship in Medical Toxicology at UT Southwestern Medical Center. He has a strong background interest in General Internal Medicine with particular interest in the care of the diabetic patient and management of chronic heart failure.
He currently specializes in the management of the poison patient, drug overdose, adverse drug reactions, work related diseases and injury.
Dr. Obafemi’s interests outside of medicine include fishing and community outreach programs.
- American College of Physicians (2008)
- North American Academy of Clinical Toxicologists (2010)
- American College of Occupational and Environmental Medicine (2010)
- American College of Medical Toxicology (2010)
ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients.
Ellis C, Devlin G, Elliott J, Matsis P, Williams M, Gamble G, Hamer A, Richards M, White H The New Zealand medical journal 2010 Jul 123 1319 44-60
Leukocytosis and hypercalcemia: a rare combination of paraneoplastic features in squamous cell penile cancer.
Doraiswamy VA, Biboa J, Obafemi A, Goldschmid M Southern medical journal 2010 May 103 5 474-6
Myocardial infarction associated with use of the synthetic cannabinoid K2.
Mir A, Obafemi A, Young A, Kane C Pediatrics 2011 Dec 128 6 e1622-7
Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002.
Ellis C, Gamble G, Hamer A, Williams M, Matsis P, Elliott J, Devlin G, Richards M, White H The New Zealand medical journal 2010 Jul 123 1319 25-43
Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, Kleinschmidt K The American journal of emergency medicine 2011 Jul
- ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients.
- Work-related diseases and injury
- Occupational asthma
- Heavy metal poisoning
- Chelation therapy
- Adult Preventive Medicine
Showing 1 locations